Clinical and statistical studies on prostatic cancer: prognostic value of clinical stage, Gleason score and age

H. Kanamaru; T. Shirahase; Y. Isogawa; S. Moroi; H. Okuno; Y. Kihara; J. Y. Kuo; T. Taniguchi; Y. Arai

Clinical and statistical studies on prostatic cancer: prognostic value of clinical stage, Gleason score and age

H. Kanamaru, T. Shirahase, Y. Isogawa, S. Moroi, H. Okuno, Y. Kihara, J. Y. Kuo, T. Taniguchi, Y. Arai

MED - Medical Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

We assessed the outcome of 200 patients with prostatic cancer treated at the Public Toyooka Hospital from 1980 to 1989. The patient's age varied from 53 to 94 years (mean 76.8). Overall actuarial survival rate at 5 and 10 years were 52% and 25%, respectively. The 5-year survival according to clinical stage was 69% for stage A, 66% for stage B, 43% for stage C and 32% for stage D disease. A significant difference was noted between the survival of patients with stage A or B and those with stage C or D. Patients with Gleason score of less than 7 showed significantly better survival as compared to those with Gleason score of 7 or more (5-year survival, 64% vs 33%). No significant difference was observed between the survival of patients under the age of 75 and those 75 or older.

Original language	English
Pages (from-to)	387-392
Number of pages	6
Journal	Hinyokika kiyo. Acta urologica Japonica
Volume	40
Issue number	5
Publication status	Published - 1994 May

ASJC Scopus subject areas

Urology

UN SDGs

This output contributes to the following Sustainable Development Goal(s)

Fingerprint Dive into the research topics of 'Clinical and statistical studies on prostatic cancer: prognostic value of clinical stage, Gleason score and age'. Together they form a unique fingerprint.

Cite this

Clinical and statistical studies on prostatic cancer : prognostic value of clinical stage, Gleason score and age. / Kanamaru, H.; Shirahase, T.; Isogawa, Y.; Moroi, S.; Okuno, H.; Kihara, Y.; Kuo, J. Y.; Taniguchi, T.; Arai, Y.

In: Hinyokika kiyo. Acta urologica Japonica, Vol. 40, No. 5, 05.1994, p. 387-392.

Research output: Contribution to journal › Article › peer-review

@article{0cb319d9d63c4dafaa912b5d27855bb1,

title = "Clinical and statistical studies on prostatic cancer: prognostic value of clinical stage, Gleason score and age",

abstract = "We assessed the outcome of 200 patients with prostatic cancer treated at the Public Toyooka Hospital from 1980 to 1989. The patient's age varied from 53 to 94 years (mean 76.8). Overall actuarial survival rate at 5 and 10 years were 52% and 25%, respectively. The 5-year survival according to clinical stage was 69% for stage A, 66% for stage B, 43% for stage C and 32% for stage D disease. A significant difference was noted between the survival of patients with stage A or B and those with stage C or D. Patients with Gleason score of less than 7 showed significantly better survival as compared to those with Gleason score of 7 or more (5-year survival, 64% vs 33%). No significant difference was observed between the survival of patients under the age of 75 and those 75 or older.",

author = "H. Kanamaru and T. Shirahase and Y. Isogawa and S. Moroi and H. Okuno and Y. Kihara and Kuo, {J. Y.} and T. Taniguchi and Y. Arai",

year = "1994",

month = may,

language = "English",

volume = "40",

pages = "387--392",

journal = "Acta Urologica Japonica",

issn = "0018-1994",

publisher = "Editorial Board of Acta Urologica Japonica",

number = "5",

}

TY - JOUR

T1 - Clinical and statistical studies on prostatic cancer

T2 - prognostic value of clinical stage, Gleason score and age

AU - Kanamaru, H.

AU - Shirahase, T.

AU - Isogawa, Y.

AU - Moroi, S.

AU - Okuno, H.

AU - Kihara, Y.

AU - Kuo, J. Y.

AU - Taniguchi, T.

AU - Arai, Y.

PY - 1994/5

Y1 - 1994/5

N2 - We assessed the outcome of 200 patients with prostatic cancer treated at the Public Toyooka Hospital from 1980 to 1989. The patient's age varied from 53 to 94 years (mean 76.8). Overall actuarial survival rate at 5 and 10 years were 52% and 25%, respectively. The 5-year survival according to clinical stage was 69% for stage A, 66% for stage B, 43% for stage C and 32% for stage D disease. A significant difference was noted between the survival of patients with stage A or B and those with stage C or D. Patients with Gleason score of less than 7 showed significantly better survival as compared to those with Gleason score of 7 or more (5-year survival, 64% vs 33%). No significant difference was observed between the survival of patients under the age of 75 and those 75 or older.

AB - We assessed the outcome of 200 patients with prostatic cancer treated at the Public Toyooka Hospital from 1980 to 1989. The patient's age varied from 53 to 94 years (mean 76.8). Overall actuarial survival rate at 5 and 10 years were 52% and 25%, respectively. The 5-year survival according to clinical stage was 69% for stage A, 66% for stage B, 43% for stage C and 32% for stage D disease. A significant difference was noted between the survival of patients with stage A or B and those with stage C or D. Patients with Gleason score of less than 7 showed significantly better survival as compared to those with Gleason score of 7 or more (5-year survival, 64% vs 33%). No significant difference was observed between the survival of patients under the age of 75 and those 75 or older.

UR - http://www.scopus.com/inward/record.url?scp=0028434333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028434333&partnerID=8YFLogxK

M3 - Article

C2 - 8023761

AN - SCOPUS:0028434333

VL - 40

SP - 387

EP - 392

JO - Acta Urologica Japonica

JF - Acta Urologica Japonica

SN - 0018-1994

IS - 5

ER -

Clinical and statistical studies on prostatic cancer: prognostic value of clinical stage, Gleason score and age

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Cite this